Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.

Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.

Despite recent advances in cancer treatment over the past 30 years, therapeutic options remain limited and do not always offer a cure for malignancy. Given that tumor-associated antigens (TAA) are, by definition, self-proteins, the need to productively engage autoreactive T cells remains at the hear...

Descripció completa

Dades bibliogràfiques
Autors principals:	Sachamitr, P, Hackett, S, Fairchild, P
Format:	Journal article
Idioma:	English
Publicat:	2014

Ítems similars

Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
per: Patty eSachamitr, et al.
Publicat: (2014-04-01)

Exploiting the use of induced pluripotent stem cell derived immune cells for immunotherapy
per: Sachamitr, S
Publicat: (2015)

Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
per: Sachamitr, P, et al.
Publicat: (2018)

Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
per: Sachamitr, P, et al.
Publicat: (2012)

Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
per: Patty Sachamitr, et al.
Publicat: (2018-01-01)

The challenge of immunogenicity in the quest for induced pluripotency.
per: Fairchild, P
Publicat: (2010)

Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture
per: Nousheen Zahoor, et al.
Publicat: (2024-12-01)

iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
per: Horton, C, et al.
Publicat: (2019)

The Opportunities and Challenges regarding Induced Platelets from Human Pluripotent Stem Cells
per: Meng-Xue Xu, et al.
Publicat: (2021-01-01)

Emerging opportunities for induced pluripotent stem cells in orthopaedics
per: Wan-Ju Li, et al.
Publicat: (2019-04-01)

Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management
per: Cossins, C, et al.
Publicat: (2021)

Haplobanking induced pluripotent stem cells for clinical use
per: Sullivan, S, et al.
Publicat: (2020)

Embryonic stem cells: protecting pluripotency from alloreactivity.
per: Fairchild, P, et al.
Publicat: (2007)

T cell immunotherapy for cervical cancer: challenges and opportunities
per: Lingfeng Yu, et al.
Publicat: (2023-04-01)

Role of T cells in cancer immunotherapy: Opportunities and challenges
per: Hossain Ahmed, et al.
Publicat: (2023-04-01)

Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy
per: Hiroaki Mashima, et al.
Publicat: (2021-06-01)

Transplantation tolerance in an age of induced pluripotency.
per: Fairchild, P
Publicat: (2009)

Human induced pluripotent stem cell-derived cardiomyocytes as an electrophysiological model: Opportunities and challenges—The Hamburg perspective
per: Djemail Ismaili, et al.
Publicat: (2023-02-01)

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities
per: Tae Wan Kim, et al.
Publicat: (2020-08-01)

Pluripotency of induced pluripotent stem cells
per: Kang Lan, et al.
Publicat: (2012-02-01)

Human induced pluripotent stem cells are capable of B-cell lymphopoiesis.
per: Carpenter, L, et al.
Publicat: (2011)

Induced pluripotent stem cells for development of cancer immunotherapy - A viable idea for less toxic treatment
per: Prof. Binafsha Manzoor Syed
Publicat: (2022-06-01)

Obtaining consent for future research with induced pluripotent cells: opportunities and challenges.
per: Katriina Aalto-Setälä, et al.
Publicat: (2009-02-01)

Addressing the immunological barriers to regenerative medicine: differentiation and characterisation of dendritic cells derived from induced pluripotent stem cells
per: Hackett, S
Publicat: (2013)

Regeneration of T cells from human-induced pluripotent stem cells for CAR-T cell medicated immunotherapy
per: Yanyan Chen, et al.
Publicat: (2023-05-01)

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
per: Amr A. Youssef, MD, PhD, et al.
Publicat: (2016-10-01)

Prospects and challenges of induced pluripotent stem cells in equine health
per: Francesc Xavier eDonadeu, et al.
Publicat: (2015-11-01)

Interconversion of Cancer Cells and Induced Pluripotent Stem Cells
per: Drishty B. Sarker, et al.
Publicat: (2024-01-01)

Natural killer cell memory: challenges and opportunities for cancer immunotherapy
per: Yuhua Qu, et al.
Publicat: (2024-12-01)

Induced Pluripotent Stem Cells
per: Chia-Yu Chang, et al.
Publicat: (2018-11-01)

Induced Pluripotent Stem Cell-Based Cancer Vaccines
per: Xiaoming Ouyang, et al.
Publicat: (2019-07-01)

Ovarian cancer immunotherapy: opportunities, progresses and challenges
per: Stevens Richard, et al.
Publicat: (2010-02-01)

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
per: Huang Zhu, et al.
Publicat: (2019-08-01)

Cancer stem cells and niches: challenges in immunotherapy resistance
per: Yonglong Pan, et al.
Publicat: (2025-02-01)

T–cell–based immunotherapy for osteosarcoma: challenges and opportunities
per: Zhan Wang, et al.
Publicat: (2016-09-01)

Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
per: Guilian Shi, et al.
Publicat: (2019-12-01)

Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research
per: Hsiao-Mei Chao, et al.
Publicat: (2018-12-01)

Induced pluripotent stem cells in dentistry
per: Paramel Mohan Sunil
Publicat: (2016-01-01)

Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges
per: Sara Guerreiro, et al.
Publicat: (2023-02-01)

Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease
per: Manoj Kumar Jaiswal
Publicat: (2017-01-01)